Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Jun:112:122-125.
doi: 10.1016/j.ejim.2023.02.014. Epub 2023 Feb 13.

Safety of COVID-19 vaccines: A comparison between adverse drug reactions among vaccines marketed in Europe

Alfredo Jose Pardo-Cabello  1 , Victoria Manzano-Gamero  2 , Juan de Dios Luna  3
Affiliations
Comment

Safety of COVID-19 vaccines: A comparison between adverse drug reactions among vaccines marketed in Europe

Alfredo Jose Pardo-Cabello et al. Eur J Intern Med. 2023 Jun.
No abstract available

Keywords: Ad26COVS1; Adverse drug reaction; COVID-19 Vaccines; CX-024414; ChAdOx1 nCoV-19; Tozinameran.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors declare that they have no competing interests.

Comment in

  • Safety of COVID-19 vaccines.
    Virginia R, Guido R. Virginia R, et al. Eur J Intern Med. 2023 Jun;112:15-16. doi: 10.1016/j.ejim.2023.04.009. Epub 2023 Apr 10. Eur J Intern Med. 2023. PMID: 37045709 Free PMC article. No abstract available.

Comment on

References

    1. Pardo-Cabello A.J., Manzano-Gamero V., Luna J.D. Comparative study of adverse drug reactions among direct-acting oral anticoagulants and vitamin K antagonists using the EudraVigilance database. Naunyn Schmiedebergs Arch Pharmacol. 2021;394(7):1477–1485. doi: 10.1007/s00210-021-02073-7. Jul. - DOI - PubMed
    1. Krzywicka K., Heldner M.R., Sánchez van Kammen M., van Haaps T., Hiltunen S., Silvis S.M., Levi M., Kremer Hovinga J.A., Jood K., Lindgren E., Tatlisumak T., Putaala J., Aguiar de Sousa D., Middeldorp S., Arnold M., Coutinho J.M., Ferro J.M. Post-SARS-CoV-2-vaccination cerebral venous sinus thrombosis: an analysis of cases notified to the European Medicines Agency. Eur J Neurol. 2021;28(11):3656–3662. doi: 10.1111/ene.15029. Nov. - DOI - PMC - PubMed
    1. Patone M., Handunnetthi L., Saatci D., Pan J., Katikireddi S.V., Razvi S., Hunt D., Mei X.W., Dixon S., Zaccardi F., Khunti K., Watkinson P., Coupland C.A.C., Doidge J., Harrison D.A., Ravanan R., Sheikh A., Robertson C., Hippisley-Cox J. Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection. Nat Med. 2021;27(12):2144–2153. doi: 10.1038/s41591-021-01556-7. Dec. - DOI - PMC - PubMed
    1. Román G.C., Gracia F., Torres A., Palacios A., Gracia K., Harris D. Acute Transverse Myelitis (ATM): clinical review of 43 patients with COVID-19-associated ATM and 3 post-vaccination ATM serious adverse events with the ChAdOx1 nCoV-19 vaccine (AZD1222) Front Immunol. 2021;12 doi: 10.3389/fimmu.2021.653786. Apr 26. - DOI - PMC - PubMed
    1. Whiteley W.N., Ip S., Cooper J.A., Bolton T., Keene S., Walker V., Denholm R., Akbari A., Omigie E., Hollings S., Di Angelantonio E., Denaxas S., Wood A., Sterne J.A.C., Sudlow C., CVD-COVID-UK consortium Association of COVID-19 vaccines ChAdOx1 and BNT162b2 with major venous, arterial, or thrombocytopenic events: a population-based cohort study of 46 million adults in England. PLoS Med. 2022;19(2) doi: 10.1371/journal.pmed. Feb 22. - DOI - PMC - PubMed